Predictors of specialized pediatric palliative care involvement and impact on patterns of end-of-life care in children with cancer: A population-based study.

Authors

null

Sumit Gupta

Hospital for Sick Children, Toronto, ON, Canada

Sumit Gupta , Rinku Sutradhar , Adam Rapoport , Katherine Nelson , Ying Liu , Christina Vadeboncouer , Shayna M. Zelcer , Alisha Kassam , Jason D Pole , Craig Earle , Joanne Wolfe , Kimberley Widger

Organizations

Hospital for Sick Children, Toronto, ON, Canada, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada, Children's Hospital of Western Ontario, London, ON, Canada, Southlake Regional Health Center, Newmarket, Ontario, Canada, Pediatric Oncology Group of Ontario, Toronto, ON, Canada, Ontario Institute for Cancer Research, Toronto, ON, Canada, Dana-Farber Cancer Institute, Boston, MA

Research Funding

Other

Background: Children with cancer are at risk of receiving high-intensity (HI) care at the end-of-life (EOL) and associated high symptom burden. The impact of palliative care (PC) delivered by generalists or of specialized pediatric palliative care (SPPC) on patterns of EOL care is unknown, with previous studies limited by small sample sizes or low response rates. Methods: Using a provincial registry, we assembled a retrospective cohort of Ontario children with cancer who died between 2000-2012 and who received care through a pediatric institution with a SPPC team and a clinical PC database. Patients were linked to population-based healthcare data capturing inpatient, outpatient, and emergency visits. Clinical PC databases were used to identify patients receiving SPPC. Remaining patients were categorized as having received either general PC (GPC) or no PC depending on the presence of PC associated physician billing or inpatient codes. We determined predictors of SPPC involvement, and whether either SPPC or GPC was associated with HI-EOL outcomes: ICU admission < 30 days from death, mechanical ventilation < 14 days from death, or in hospital death. Sensitivity analyses excluded treatment-related mortality (TRM) cases. Results: 572 patients met inclusion criteria. Children less likely to receive SPPC services included those with hematologic cancers [odds ratio (OR) 0.33, 95th confidence interval (CI) 0.30-0.37; p < 0.001)], in the lowest income quintile (OR 0.44, 95CI 0.23-0.81; p = 0.009), and living at increased distance from the treatment center (OR 0.46, 95CI 0.40-0.52; p < 0.0001). In multivariate analysis, SPPC was associated with a 3-fold decrease in the odds of an EOL ICU admission (OR 0.32, 95CI 0.18-0.57), while GPC had no impact. Similar associations were seen with all other HI-EOL indicators. Excluding TRM had little impact. Conclusions: SPPC, but not GPC, is associated with lower intensity care at EOL. Access to such care however remains uneven. In the absence of randomized trials, these results provide the strongest evidence to date supporting the creation of SPPC teams. These results can be used to support PC advocacy and policy efforts.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Symptom Management/Supportive Care/Palliative Care

Citation

J Clin Oncol 35, 2017 (suppl; abstr 10573)

DOI

10.1200/JCO.2017.35.15_suppl.10573

Abstract #

10573

Poster Bd #

330

Abstract Disclosures

Similar Abstracts

First Author: Logan Cole Houston

Abstract

2019 Supportive Care in Oncology Symposium

Impact of mortality reviews on supportive care utilization, end-of-life care, and inpatient mortality.

First Author: Yasmin Karimi

First Author: Chinwe Udemgba